Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Diagnostic accuracy of the  non-invasive markers NFLS,  NI-NASH-DS, and FIB-4 for assessment of different aspects of non-alcoholic fatty liver disease  in individuals with obesity:  cross-sectional study

HIGHLIGHTS

  • In a bariatric population, more than 90% of the patients presented with histopathological steatosis and some degree of fibrosis, whereas over 20% had active NASH.
  • FIB-4 score had high overall accuracy in assessing the presence of advanced liver fibrosis in individuals with obesity.
  • NFLS score was moderately accurate for the assessment of hepatic steatosis in individuals with obesity.
  • NI-NASH-DS was moderately accurate for the assessment of NASH in individuals with obesity.

 

ABSTRACT – Background –

Non-invasive markers have been developed to assess the presence and severity of liver abnormalities related to non-alcoholic fatty liver disease (NAFLD). Objective – To analyze the diagnostic accuracy of non-invasive NAFLD markers (NAFLD liver fat score [NLFS], noninvasive non-alcoholic steatohepatitis detection score [NI-NASH-DS] and f ibrosis score based on four variables [FIB-4]) in individuals with obesity undergoing bariatric surgery. Methods – A descriptive retrospective crosssectional study was carried out enrolling 91 individuals who underwent bariatric surgery at a tertiary-level public university hospital. Non-invasive NAFLD markers were calculated using laboratory tests, clinical and anthropometric variables and diagnostic accuracy tests were calculated comparing them in relation to the gold-standard test for this analysis (histopathological evaluation). Results – A total of 85.7% of the participants were female and mean age was 39.1±9.8 years. The average body mass index was 38.4±3.6 kg/m2. At histopathological examination, 84 (92.3%) patients presented with steatosis, 82 (90.1%) with some type of fibrosis; 21 (23.1%) patients were diagnosed with NASH according to the NAFLD activity score criteria. The overall accuracy of NLFS score was 58.2% for general hepatic steatosis and 61.5% for moderate to severe steatosis. The overall accuracy of FIB-4 was 95.4% for advanced fibrosis. NI-NASH-DS had a 74.7% overall accuracy for NASH. Conclusion – In a population of individuals with obesity, the FIB-4 score had high overall accuracy in assessing the presence of advanced liver fibrosis, whereas the NFLS and NI-NASH-DS had moderate accuracies for the assessment of steatosis and NASH, respectively. Keywords – Non-alcoholic fatty liver disease; obesity; liver function tests; fatty liver; biomarkers.

 

AUTORES

Gustavo Macedo HADDAD1, Martinho Antonio GESTIC2, Murillo Pimentel UTRINI2, Felipe David Mendonça CHAIM2, Elinton Adami CHAIM2 and Everton CAZZO2.